4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001209191-24-000779
Chief Executive Officer sold 2,616 shares at an average $63.89 ($167,144)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT Chief Executive Officer | 2024-01-02 | Sale 10b5-1 | −127 | $62.93 | $7,992 | 152,467 | I |
| PICKERING GRANT Chief Executive Officer | 2024-01-02 | Sale 10b5-1 | −594 | $63.65 | $37,810 | 151,873 | I |
| PICKERING GRANT Chief Executive Officer | 2024-01-02 | Sale 10b5-1 | −587 | $64.33 | $37,763 | 151,286 | I |
| PICKERING GRANT Chief Executive Officer | 2024-01-02 | Sale 10b5-1 | −97 | $62.91 | $6,102 | 152,497 | I |
| PICKERING GRANT Chief Executive Officer | 2024-01-02 | Sale 10b5-1 | −568 | $63.68 | $36,171 | 151,929 | I |
| PICKERING GRANT Chief Executive Officer | 2024-01-02 | Sale 10b5-1 | −643 | $64.24 | $41,304 | 151,286 | I |
| Open-market sales · 2,616 sh · avg $63.89 · $167,144 | |||||||
Loading xslF345X05/doc4.xml…